Filter posts

MERS, Patents, and Material Transfer Agreements: What WHO Didn't Know

The outbreak of the Middle East Respiratory Syndrome (MERS-CoV), a SARS like virus has lead …

Myriad Supreme Court Decision: BIO’s Statement

Statement On U.S. Supreme Court Review Of Isolated DNA Patents Washington, D.C. (June 13, 2013) …

IP in Latin America: Growing Recognition of the Importance of IP to Innovation

The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin …

Gene Patents, Angelina Jolie, and Reality

By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization  Angelina …

Canada Patent Utility: Former USPTO Director Interview at BIO Convention

David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and …

What OxyContin Tells Us About the Value of “Evergreening" and Patents

A few weeks ago, the  FDA announced that they would not allow generic versions of …

The Justness of Gene Patents

Most of the biotechnology world awaits the U.S. Supreme Court’s answer to the Question Presented, …

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated …

BIO Members Receive Patents for Humanity Award

The United States Patent and Trademark Office announced the winners of the Patents for Humanity …

Patent and Tech Transfer Sessions at 2013 BIO International Convention

Patent and Technology Transfer sessions feature prominently at the 2013 BIO International Convention in Chicago …